Home
The Department of Biomedicine

BBB seminar: Stephen V. Faraone

The genetics of attention deficit hyperactivity disorder

Main content

Stephen V. Faraone
Genetics Research Program and Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA

Results of behavioral genetic and molecular genetic studies have converged to suggest that both genetic and non-genetic factors contribute to the development of attention deficit hyperactivity disorder (ADHD). We review this literature, with a particular emphasis on molecular genetic studies. Family, twin and adoption studies provide compelling evidence that genes play a strong role in mediating susceptibility to ADHD. This fact is most clearly seen in the twenty extant twin studies, which estimate the heritability of ADHD to be 0.76. Molecular genetic studies suggest that the genetic architecture of ADHD is complex. The handful of genome-wide scans conducted thus far are not conclusive. In contrast, the many candidate gene studies of ADHD have produced substantial evidence implicating several genes in the etiology of the disorder. For the eight genes for which the same variant has been studied in three or more case-control or family-based studies, seven show statistically significant evidence of association with ADHD based on the pooled odds ratio across studies: DRD4, DRD5, DAT, DBH, 5-HTT, HTR1B, and SNAP25.

Host: Jan Haavik, Department of Biomedicine

Stephen V. Faraone

Director, Genetics Research Program; Professor of Psychiatry and Behavioral Sciences; Director, Child and Adolescent Psychiatry Research, SUNY Upstate Medical University, Syracuse, NY, USA

Dr. Faraone is one of the world's leading authorities on the genetics of psychiatric disorders and has also made substantial contributions to research in psychopharmacology and research methodology. An author of over 400 journal articles, editorials, chapters and books, he has been recognized by the Institute for Scientific Information for his high-impact papers in the field of psychiatry. In 2002, he was inducted into the Children and Adults with Attention Deficit Disorders (CHADD) Hall of Fame in recognition of outstanding achievements in medicine and education research on attention disorders and in 2003 he was elected to the Board of Directors of the International Society of Psychiatric Genetics.